Abstract:
The Role of Chemokine Receptor CCR7 in Dissemination of T Cell LymphomaJing YANG1,4, ShengyiWANG2, Guofan ZHAO1,4, Baocun SUN1,3, 4Correspondence to: Baocun SUN, E-mail: sunbaocun@yahoo.com.cn1Teaching and Research Section of Pathology, Tianjin Medical University, Tianjin 300070, China2Department of Medical Psychology, Tianjin Medical University, Tianjin 300070, China3Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China4Department of Pathology, General Hospital of Tianjin Medical University, Tianjin 300052, ChinaThis work was supported by Tianjin Municipal Projects for Scientific Development Support (Sino-Swiss International Cooperation, No.09ZCZDSF04400)Abstract Objective: To explore the role and mechanisms of chemokine receptors in the T-cell lymphoma invasion process in or-der to provide experimental and theoretical basis for target therapy of T-cell lymphoma. Methods: The cutaneous T-cell lymphomaHut78 and adult T-cell leukemia/lymphoma Jurkat cell lines were co-cultured. The in vitro invasive ability of the two cell lines was mea-sured by Transwell invasion assay. The transcription and expression of CCR7 and key enzymes in PI3K/Akt pathway were evaluated us-ing RT-PCR and Western blot. Results: Hut78 cell lines showed a stronger invasive ability in the Transwell assay. After the two celllines were co-cultured with chemokine CCL21, their invasive ability was increased. The invasive ability displayed a positive correlationwith the CCL21 concentration. The CCR7 mRNA, PI3K mRNA and Akt mRNA expression was all higher in Hut78 cell line than in Jur-kat cell line, with significant differences ( P < 0.001 ). The expression of CCR7 and pAkt protein was significantly higher in Hut78 cellline than in Jurkat cell line ( P < 0.05 ). Conclusion: The high expression of CCR7 in T-cell lymphoma is related to the invasion of tu-mors. CCR7 may promote tumor invasion and metastasis through the PI3K/Akt signal pathways.Keywords CCR7; PI3K/Akt signal transduction pathway; T cell lymphoma